RC Medical Venture Studio Partners with Physicians to Launch IR Device Newcos

RC Medical, a medical device venture studio based in Lake Forest, California, is flipping the traditional medtech innovation model on its head. Instead of starting with an engineer’s idea and searching for a clinical problem, the company begins in the interventional suite, listening to physicians about the gaps they see every week. Led by CEO David Ferrera, who brings nearly 30 years of experience in interventional neuroradiology and related fields—including roles as CTO of Balt Global and co-founder of Blockade Medical—RC Medical partners directly with physician-entrepreneurs to identify new technology and new indications for devices. The studio then funds, designs, develops, and commercializes products for the interventional radiology market, forming a standalone company around each viable idea rather than folding it into an existing product line.

Ferrera describes the relationship with physicians as a true partnership that runs from the first sketch through commercialization. “A physician knows the problem better than anyone,” he says. “What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients.” This division of labor is the core of the studio model: the physician stays close to the clinical need while RC Medical manages product development, funding, and the business structure needed to commercialize it. That approach has already produced three separate companies—Single Pass, Infinity Neuro, and Sonorous NV—each born from a specific problem a physician described in the interventional suite. Ferrera emphasizes that each idea gets its own company, its own team, and its own focus, because “a big portfolio company can lose a good idea in the shuffle. A newco can’t afford to.”

Ferrera’s experience has taught him that the physicians performing these procedures see problems that never make it into a traditional product roadmap. “A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week,” he notes. The studio model is designed to catch those details early, before a device design is locked in. Not every idea is a fit—Ferrera is honest with physicians about whether an idea is better as a feature of an existing product rather than a new company—but for those that do become a newco, the physician’s involvement often continues through development and toward the market, keeping the clinical need in view at every stage. Ferrera is also the author of “Innovation in Translation: How Big Ideas Really Happen,” published by Forbes Books in 2021.